Richaud Thomas, Lacaze Kevin, Fassio Alexandre, Nicolas Paul, Ourliac Maxime, Hennart Benoit, Ina Jason G, Sonnery-Cottet Bertrand, Cavaignac Etienne
Department of Orthopaedic Surgery, Hopital Pierre-Paul Riquet, Toulouse, France.
Sport Pro Santé, Toulouse, France.
Video J Sports Med. 2024 Aug 15;4(4):26350254241241084. doi: 10.1177/26350254241241084. eCollection 2024 Jul-Aug.
Arthrogenic muscle inhibition (AMI) is a complex neurological phenomenon that is actually very common. AMI can appear following a knee injury or knee surgery. If it is not addressed, the patient's function can be negatively affected. There is currently no specific tool for the diagnosis and treatment of AMI.
Following surgery or injury to the knee, AMI causes defective activation of the quadriceps, sometimes combined with a knee extension deficit. A clinical classification of AMI has been proposed recently to help with making the diagnosis and to guide treatment. In this article, we describe how biofeedback and surface electromyography (EMG) can be used in the early diagnosis and treatment of knee AMI.
Biofeedback is based on transformation of physiological variables into a visual or auditory signal. This allows the patient to learn how to control physical and bodily functions, which were previously considered as involuntary processes. This technique requires the use of a specific device that transforms the measured physiological signals-neuromuscular activation in this instance-into visual signals. This tool incorporates surface EMG, with electrodes connected to a measuring unit. This unit is connected to a screen that shows the neuromuscular activation in real time. Thus, EMG biofeedback can be used to help clinicians make a diagnosis and to specifically treat the AMI.
We have used biofeedback in patients who have a knee injury or who have undergone knee surgery. Both the therapist and patient were able to objectively see the presence of AMI using the biofeedback device. For treatment, the therapist works with a patient by providing clear instructions and increasingly more challenging goals. We show examples of how patients were able to eliminate their AMI by using biofeedback.
DISCUSSION/CONCLUSION: EMG biofeedback is a promising tool for the diagnosis and treatment of AMI after an anterior cruciate ligament (ACL) tear and ACL reconstruction surgery. The next steps are to define thresholds and a rehabilitation protocol that will be used in a clinical trial.
The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
关节源性肌肉抑制(AMI)是一种复杂的神经学现象,实际上非常常见。AMI可出现在膝关节损伤或膝关节手术后。如果不加以处理,患者的功能会受到负面影响。目前尚无诊断和治疗AMI的特定工具。
膝关节手术或损伤后,AMI会导致股四头肌激活缺陷,有时还伴有膝关节伸展功能障碍。最近有人提出了AMI的临床分类方法,以帮助诊断和指导治疗。在本文中,我们描述了生物反馈和表面肌电图(EMG)如何用于膝关节AMI的早期诊断和治疗。
生物反馈基于将生理变量转化为视觉或听觉信号。这使患者能够学会如何控制以前被认为是无意识过程的身体和生理功能。该技术需要使用特定设备,将测量到的生理信号(在这种情况下为神经肌肉激活)转化为视觉信号。该工具结合了表面肌电图,电极连接到测量单元。该单元连接到一个实时显示神经肌肉激活情况的屏幕。因此,EMG生物反馈可用于帮助临床医生进行诊断并专门治疗AMI。
我们已将生物反馈应用于膝关节损伤或接受过膝关节手术的患者。治疗师和患者都能够通过生物反馈设备客观地观察到AMI的存在。在治疗过程中,治疗师通过提供明确的指导和越来越具挑战性的目标与患者合作。我们展示了患者如何通过使用生物反馈消除AMI的示例。
讨论/结论:EMG生物反馈是诊断和治疗前交叉韧带(ACL)撕裂和ACL重建手术后AMI的一种有前景的工具。接下来的步骤是确定将在临床试验中使用的阈值和康复方案。
作者证明已获得本出版物中出现的任何患者的同意。如果个体可能被识别,作者已随本提交的出版物包含患者的豁免声明或其他书面批准形式。